Age and malignant melanoma: Comparison of variables in different age-groups - 06/10/17
Résumé |
Variables were compared in patients with clinical stage I superficial spreading melanoma who had been divided into three age-groups. The study included 736 consecutive patients who were prospectively entered into the data base of the Melanoma Cooperative Group of New York University Medical Center. Compared with the younger patients (<40 years), older patients (≥ 60 years) had superficial spreading melanomas that were, on average, of greater thickness, level, and diameter. Younger patients were more likely than older patients to show evidence that their melanomas arose from preexisting nevocytic nevi. There was no difference in the 10-year survival between groups when melanomas were matched by thickness. Thus it is as important to perform periodic total cutaneous examinations in the elderly as it is in younger persons, and age alone should not determine management strategies.
Le texte complet de cet article est disponible en PDF. Supported by the Melanoma Funds of the New York University School of Medicine Departments of Dermatology and Surgery; the David A. Leinbach Memorial Melanoma Fund and the Niarchos Fund of the Skin Cancer Foundation; NYU Cancer Center (Core Support Grant No. P30 CA-16087); National Cancer Institute Grant No. 2 RIO CA 1366-05; the Rudolf L. Baer Foundation for Diseases of the Skin; National Institute of Occupational Safety and Health Grant No. RO1 OH00915; the Department of Energy Grant No. EY-76-C-023077; and the Ontario Ministry of Health. The results and conclusions are those of the authors, and no official endorsement by the Ontario Ministry of Health is intended nor should be inferred. |
Vol 21 - N° 4P1
P. 717-722 - octobre 1989 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?